Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers
14 pages
English

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris

Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus
14 pages
English
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus

Description

We have recently published some work on CEA levels in hookah (also called narghile, shisha elsewhere) and cigarette smokers. Hookah smokers had higher levels of CEA than non-smokers although mean levels were low compared to cigarette smokers. However some of them were also users of other tobacco products (cigarettes, bidis, etc.). Objectives To find serum CEA levels in ever/exclusive hookah smokers, i.e. those who smoked only hookah (no cigarettes, bidis, etc.), prepared between 1 and 4 times a day with a quantity of up to 120 g of a tobacco-molasses mixture each (i.e. the tobacco weight equivalent of up to 60 cigarettes of 1 g each) and consumed in 1 to 8 sessions. Methods Enhanced chemiluminescent immunometric technique was applied to measure CEA levels in serum samples from 59 exclusive male smokers with age ranging from 20–80 years (mean = 58.8 ± 14.7 years) and 8–65 years of smoking (mean = 37.7 ± 16.8). 36 non-smokers served as controls. Subjects were divided into 3 groups according to the number of preparations; the number of sessions and the total daily smoking time: Light (1; 1; ≤ 20 minutes); Medium (1–3; 1–3; >20 min to ≤ 2 hrs) and Heavy smokers (2–4; 3–8; >2 hrs to ≤ 6 hrs). Because of the nature of distribution of CEA levels among our individuals, Wilcoxon's rank sum two-sample test was applied to compare the variables. Results The overall CEA levels in exclusive hookah smokers (mean: 3.58 ± 2.61 ng/ml; n = 59) were not significantly different (p ≤ 0.0937) from the levels in non-smokers (2.35 ± 0.71 ng/ml). Mean levels in light, medium and heavy smokers were: 1.06 ± 0.492 ng/ml (n = 5); 2.52 ± 1.15 ng/ml (n = 28) and 5.11 ± 3.08 ng/ml (n = 26) respectively. The levels in medium smokers and non-smokers were also not significantly different (p ≤ 0.9138). In heavy smokers, the CEA levels were significantly higher than in non-smokers (p ≤ 0.0001567). Conclusion Overall CEA levels in exclusive hookah smokers were low compared to cigarette smokers. However, heavy hookah smoking substantially raises CEA levels. Low-nitrosamines smokeless tobacco of the SNUS Swedish type could be envisaged as an alternative to smoking for this category of users and also, in a broad harm reduction perspective, to the prevalent low-quality moist snuff called naswar.

Informations

Publié par
Publié le 01 janvier 2008
Nombre de lectures 15
Langue English
Poids de l'ouvrage 3 Mo

Extrait

Pga e 1fo1 (4apegum nr bet nor foaticnoitrup esops)
Address: 1 Multan Institute of Nuclear Medicine and Radiotherapy (MINAR), Multan, Pakistan, 2 Paris XI University (Lecturer DIU Tabacologie/ Narghile), Paris Sud, France and 3 MINAR (Scientific Collabor ator), Multan, Pakistan Email: Khan Mohammad Sajid* - kmsajid@yahoo.com; Kamal Chaou achi - kamcha@gmail.com; Ruba ida Mahmood - kmsajid@yahoo.com * Corresponding author
Research Open Access Hookah smoking and cancer: ca rcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers Khan Mohammad Sajid* 1 , Kamal Chaouachi 2,3 and Rubaida Mahmood 1
Abstract Background: We have recently published some work on CEA levels in hookah (also called narghile, shisha elsewhere) and cigarette smokers. Hookah smokers had higher levels of CEA than non-smokers although mean levels were low co mpared to cigarette smokers. However some of them were also users of other tobacco products (cigarettes, bidis, etc.). Objectives: To find serum CEA levels in ever/exclusi ve hookah smokers, i.e. those who smoked only hookah (no cigarettes, bidis, etc.), prepared between 1 and 4 times a day with a quantity of up to 120 g of a tobacco-molasses mi xture each (i.e. the tobacco we ight equivalent of up to 60 cigarettes of 1 g each) and co nsumed in 1 to 8 sessions. Methods: Enhanced chemiluminescent immunometric technique was applied to measure CEA levels in serum samples from 59 exclusive male smokers with age ranging from 20–80 years (mean = 58.8 ± 14.7 years) and 8–65 years of smoking (mean = 37.7 ± 16.8). 36 non-smokers served as controls. Subjects were divided into 3 groups according to the number of preparations; the number of sessions and the total dail y smoking time: Light (1; 1; 20 minutes); Medium (1–3; 1–3; >20 min to 2 hrs) and Heavy smokers (2–4; 3–8; >2 hrs to 6 hrs). Because of the nature of distribution of CEA levels among our individuals, Wilcoxon s rank sum two-sample test was applied to compare ' the variables. Results: The overall CEA levels in exclusive hookah smokers (mean: 3.58 ± 2.61 ng/ml; n = 59) were not significantly different (p 0.0937) from the levels in non-smokers (2.35 ± 0.71 ng/ml). Mean levels in light, medium and heavy smoker s were: 1.06 ± 0.492 ng/ml (n = 5); 2.52 ± 1.15 ng/ ml (n = 28) and 5.11 ± 3.08 ng/ml (n = 26) resp ectively. The levels in medium smokers and non-smokers were also not significantly different (p 0.9138). In heavy smokers, the CEA levels were significantly higher than in non-smokers (p 0.0001567). Conclusion: Overall CEA levels in exclusive hookah smokers were low compared to cigarette smokers. However, heavy hookah smoking subs tantially raises CEA levels. Low-nitrosamines smokeless tobacco of the SNUS Swedish type could be envisaged as an alternative to smoking for this category of users and also, in a broad harm reduction perspective, to the prevalent low-quality moist snuff called naswar.
Published: 24 May 2008 Received: 12 March 2008 Harm Reduction Journal 2008, 5 :19 doi:10.1186/1477-7517-5-19 Accepted: 24 May 2008 This article is available from: http:// www.harmreductionjournal.com/content/5/1/19 © 2008 Sajid et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons. org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the orig inal work is properly cited.
Harm Reduction Journal
Bio Med Central
  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents